PERSPECTA

News from every angle

← Back to headlines

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China

4 Mar, 07:13 — 4 Mar, 07:13
PostShare
Only 1 source covers this story